Accelerate the adoption of novel digital clinical measures in clinical research
The challenge
Digital clinical measures that are meaningful to patients are revolutionizing how we evaluate health. Yet, some of the greatest value associated with digital endpoints remains out of reach. This is especially true for novel digital clinical measures that capture symptoms of disease that haven’t been measured before.
The solution
To address this, DATAcc has developed the Validating Novel Digital Clinical Measures resources for DHT developers and biostatisticians.
Adopting these resources in your work will unlock the full potential of novel digital clinical measures for scientific and clinical decision-making, ultimately for new therapies to reach patients. These resources will accelerate the adoption of digital endpoints in clinical research and related regulatory interactions.
Resources designed for you
Use these resources to establish a clear decision process for designing and conducting analytical validation for your digital clinical measure of interest, whether it is for a novel or previously assessed outcome.
DHT developers
Accelerate your analytical validation studies and streamline your interaction with regulators
Support your colleagues in developing statistically sound analytical validation studies and access a simulation toolkit to quickly game out more complex reference measure comparisons